FERLAZZO, GUIDO
 Distribuzione geografica
Continente #
EU - Europa 10.253
AS - Asia 1.298
NA - Nord America 668
SA - Sud America 103
AF - Africa 20
Totale 12.342
Nazione #
IT - Italia 10.032
US - Stati Uniti d'America 649
SG - Singapore 553
CN - Cina 365
VN - Vietnam 257
FR - Francia 133
BR - Brasile 74
HK - Hong Kong 44
DE - Germania 26
FI - Finlandia 24
AR - Argentina 15
IN - India 11
GB - Regno Unito 10
MX - Messico 10
IQ - Iraq 9
CH - Svizzera 8
ID - Indonesia 8
JP - Giappone 8
BD - Bangladesh 7
ZA - Sudafrica 7
CA - Canada 5
IE - Irlanda 5
CL - Cile 4
CO - Colombia 4
PK - Pakistan 4
UZ - Uzbekistan 4
KE - Kenya 3
PH - Filippine 3
SA - Arabia Saudita 3
SN - Senegal 3
TH - Thailandia 3
TR - Turchia 3
AL - Albania 2
AT - Austria 2
ES - Italia 2
IL - Israele 2
KR - Corea 2
MA - Marocco 2
NL - Olanda 2
NP - Nepal 2
PL - Polonia 2
PY - Paraguay 2
TN - Tunisia 2
TW - Taiwan 2
UA - Ucraina 2
VE - Venezuela 2
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
CY - Cipro 1
GA - Gabon 1
GE - Georgia 1
JM - Giamaica 1
JO - Giordania 1
LB - Libano 1
MR - Mauritania 1
MY - Malesia 1
PE - Perù 1
PS - Palestinian Territory 1
RU - Federazione Russa 1
RW - Ruanda 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
TT - Trinidad e Tobago 1
VC - Saint Vincent e Grenadine 1
YE - Yemen 1
Totale 12.342
Città #
Genova 4.955
Genoa 3.366
Vado Ligure 962
Rapallo 670
San Jose 293
Singapore 203
Ashburn 134
Lauterbourg 116
Ho Chi Minh City 76
Hanoi 63
Hong Kong 40
Beijing 34
New York 33
Council Bluffs 32
St Louis 30
Helsinki 24
Frankfurt am Main 23
Santa Clara 22
Bordighera 20
Haiphong 14
Da Nang 13
Tianjin 13
Orem 9
Tokyo 8
Los Angeles 7
Shanghai 7
Zurich 7
Mexico City 6
Rome 6
Milan 5
North Charleston 5
São Paulo 5
Baghdad 4
Chicago 4
Manchester 4
Naples 4
Phủ Lý 4
Santo André 4
Scandicci 4
Tashkent 4
Dakar 3
Dallas 3
Dublin 3
Hải Dương 3
Johannesburg 3
Montreal 3
Nairobi 3
Nha Trang 3
Ninh Bình 3
Palermo 3
Buenos Aires 2
Campinas 2
Cardiff 2
Charlotte 2
Denver 2
Duque de Caxias 2
Extrema 2
Go Vap 2
Guangzhou 2
Houston 2
Huế 2
Juiz de Fora 2
Leipzig 2
Maricá 2
Marrakesh 2
Marseille 2
Medellín 2
Medina 2
Midrand 2
Mumbai 2
Paris 2
Praia Grande 2
Rondonópolis 2
Sarzana 2
Surakarta 2
Suzhou 2
São José dos Campos 2
Tel Aviv 2
Thanh Hóa 2
The Dalles 2
Thái Bình 2
Uberlândia 2
Ân Thi 2
Al Hillah 1
Alterosa 1
Amman 1
Amsterdam 1
Angeles City 1
Ankara 1
Aracati 1
Assaí 1
Asunción 1
Atlanta 1
Ba Dinh 1
Bagé 1
Baku 1
Balıkesir 1
Bangkok 1
Basauri 1
Bathinda 1
Totale 11.346
Nome #
Multipotent mesenchymal stromal cells from amniotic fluid: solid perspectives for clinical application. 235
Dendritic cell editing by natural killer cells. 220
A mixture of bacterial mechanical lysates is more efficient than single strain lysate and of bacterial-derived soluble products for the induction of an activating phenotype in human dendritic cells 206
In vitro VLA-4 blockade results in an impaired NK cell-mediated immune surveillance against melanoma 197
A non-canonical adenosinergic pathway led by CD38 in human melanoma cells induces suppression of T cell proliferation 195
T lymphocytes express B7 family molecules following interaction with dendritic cells and acquire bystander costimulatory properties 183
An Historical Overview: The Discovery of How NK Cells Can Kill Enemies, Recruit Defense Troops, and More 180
Detection of MAGE-1, -2, and -3 messenger RNA in tissue samples derived from lung and mammary tumors. 178
Mucosal Immunology and Probiotics. 178
NCR + ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures 178
Engagement of CD33 surface molecules prevents the generation of dendritic cells from both monocytes and CD34+ myeloid precursors. 175
Molecular mechanisms directing migration and retention of natural killer cells in human tissues 173
Characterization of human afferent lymph dendritic cells from seroma fluids. 171
Novel perspectives on dendritic cell-based immunotherapy of cancer 169
Human NK cells and NK receptors 168
Adherent neoplastic cells grown at confluence downregulate HLA class I expression and enhance their susceptibility to lysis mediated by natural killer cells. 166
Dendritic cell editing by activated natural killer cells results in a more protective cancer-specific immune response. 166
CD56(bright)perforin(low) noncytotoxic human NK cells are abundant in both healthy and neoplastic solid tissues and recirculate to secondary lymphoid organs via afferent lymph. 165
NK cells provide helper signal for CD8+ T cells by inducing the expression of membrane-bound IL-15 on DCs 164
The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors. 163
Arginase 2 is expressed by human lung cancer, but it neither induces immune suppression, nor affects disease progression 162
Human dendritic cells activate resting Natural Killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. 160
Amniotic fluid contains multipotent mesenchymal stromal cells with high proliferative potential and safety features: solid perspectives for clinical application 160
Dendritic cells efficiently cross-prime HLA class I restricted cytolytic T lymphocytes when pulsed with both apoptotic and necrotic cells but not with soluble cell-derived lysates. 157
IFN-alpha mediates the up-regulation of HLA class I on melanoma cells without switching proteasome to immunoproteasome 156
Surface receptors and functional interactions of human natural killer cells: from bench to the clinic 152
CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells 152
CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation. 152
Membrane transfer from tumor cells overcomes deficient phagocytic ability of plasmacytoid dendritic cells for the acquisition and presentation of tumor antigens. 144
Cross-Talks between Natural Killer Cells and Distinct Subsets of Dendritic Cells 144
Distinctive lack of CD48 expression in subsets of human dendritic cells tunes NK cell activation. 144
Influence of Vitamin D in Advanced Non-Small Cell Lung Cancer Patients Treated with Nivolumab 144
Susceptibility of human melanoma cells to autologous natural killer (NK) cell killing: HLA-related effector mechanisms and role of unlicensed NK cells 142
Symptomatic carotid atherosclerotic plaques are associated with increased infiltration of natural killer (NK) cells and higher serum levels of NK activating receptor ligands 142
The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell ig-like receptors and become cytolytic. 139
Seroma fluid subsequent to axillary lymph node dissection for breast cancer derives from an accumulation of afferent lymph. 138
Phenotypic, functional and molecular analysis of lymphocytes associated with bladder cancer. 138
Distinct gut-derived lactic acid bacteria elicit divergent dendritic cell-mediated NK cell responses 135
Role of natural killer cells in the pathogenesis and progression of multiple sclerosis 134
Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs. 133
Do NK cells play a role in the possible association between natalizumab treatment and the development of melanoma? 132
Targeting ctla-4 directly on melanoma cells: A possible novel perspective in the immunotherapy of cutaneous melanoma. 130
Association Between Response to Nivolumab Treatment and Peripheral Blood Lymphocyte Subsets in Patients With Non-small Cell Lung Cancer 129
The Immune Inhibitory Receptor LAIR-1 Is Highly Expressed by Plasmacytoid Dendritic Cells and Acts Complementary with NKp44 to Control IFNα Production. 124
Cognate HLA absence in trans diminishes human NK cell education 121
Human natural killer cell function and their interactions with dentritic cells. 120
The interaction between NK cells and dendritic cells in bacterial infections results in rapid induction of NK cell activation and in the lysis of uninfected dendritic cells 119
Effector and regulatory events during natural killer-dendritic cell interactions 118
Morphological, phenotypic and karyotypic characterization of a novel natural-killer-cell target - evidence of involvement of MHC class-I molecules in NK cell recognition. 112
NK cells of human secondary lymphoid tissues enhance T cell polarization via IFN-gamma secretion 111
The anti-tumor activity of bacillus Calmette-Guerin in bladder cancer is associated with an increase in the circulating level of interleukin-2. 110
Natural Killer cells infiltrating human non-small cell lung cancer are enriched in CD56bright CD16- cells and display an impaired capability to kill tumor cells 110
Therapeutic Implications of Tumor Microenvironment in Lung Cancer: Focus on Immune Checkpoint Blockade 110
Heterogeneity of the alpha-interferon-mediated overexpression of class-I and class-II major histocompatibility complex molecules in primary cultured cancer cells. 107
Myeloma cells induce the accumulation of activated CD94low NK cells by cell-to-cell contacts involving CD56 molecules 105
CTLA-4 is expressed by human monocyte-derived dendritic cells and regulates their functions. 100
Update on natural killer cells: cross-talk with dendritic cells and role in the cure of acute myeloid leukemias. 98
NK cells at the interface between innate and adaptive immunity 97
Treatment of superficial bladder cancer with intravesical perfusion of rIL-2: a follow-up study. 96
Mechanical bacterial lysate administration prevents exacerbation in allergic asthmatic children—The EOLIA study 90
The engagement of ctla-4 on primary melanoma cell lines induces antibody-dependent cellular cytotoxicity and tnf-alpha production. 86
A think tank of TINK/TANKs: tumor-infiltrating/tumor-associated natural killer cells in tumor progression and angiogenesis 84
Mechanical bacterial lysate enhances antimicrobial barrier mechanisms in human airway epithelial cells 82
Il recettore CTLA-4 è espresso dalle cellule dendritiche umane e ne regola le funzioni. 82
An historical overview: The discovery of how NK cells can kill enemies, recruit defense troops, and more 74
Cognate HLA absence diminishes human NK cell education in trans 71
Acquisition and presentation of tumor antigens by dendritic cells 70
A PHASE-I STUDY OF INTRAVESICAL CONTINUOUS PERFUSION OF RECOMBINANT INTERLEUKIN-2 IN PATIENTS WITH SUPERFICIAL BLADDER- CANCER 69
Vitamin D plasma level can affect nivolumab drug exposure in a cohort of patients with non-small-cell lung cancer 67
Adaptative immunotherapy of advanced solid tumors 63
Anti-Bacterial Adhesion on Abiotic and Biotic Surfaces of the Exopolysaccharide from the Marine Bacillus licheniformis B3-15 61
Anti-SARS-CoV2 IgG are present in the amniotic fluid of both infected and vaccinated women at second trimester of pregnancy: a cohort study 57
Biological parameters in breast cancer 56
Interactions between natural killer and dendritic cells during bacterial infections 55
FITC-labelled clone from phage display for direct detection of leukemia cells in blood 55
Attenuated immune control of Epstein–Barr virus in humanized mice is associated with the multiple sclerosis risk factor HLA-DR15 55
Evaluation of the canonical/non-canonical Wnt signalling pathways during oxidative stress in colorectal cancer cell line models 54
Analysis of HLA-class-I specific natural killer cell receptors expressed on T lymphocytes infiltrating non-small-cell lung cancer 54
Dendritic Cell-Based Immunotherapy of Cancer: Current Pitfalls and Challenges 50
Neutrophil-like Monocytes Increase in Patients with Colon Cancer and Induce Dysfunctional TIGIT+ NK Cells 50
Isolation and Analysis of Human Natural Killer Cell Subsets 47
Curcumin ameliorates the in vitro efficacy of carfilzomib in human multiple myeloma U266 cells targeting p53 and NF-kB pathways 46
Changes in plasma 5-HT levels and equine leukocyte SERT expression in response to treadmill exercise 46
A multivariate analysis of Multiple Myeloma subtype plasma cells 46
Expansion of natural killer cells in patients with head and neck cancer: Detection of "noninhibitory" (activating) killer Ig-like receptors on circulating natural killer cells 45
Cytotoxic effects of high energy shock waves on cancer cells linked to metallic beads vehicled by monoclonal antibodies 45
NK cell compartments and their activation by dendritic cells 45
T cell polarizing properties of probiotic bacteria 45
Biofilm Development and Approaches to Biofilm Inhibition by Exopolysaccharides 44
Oxidative stress induces Wnt canonical/non-canonical pathways modulation in colon cancer cell models 44
Identification of Natural Killer Cells in Tissues and Their Isolation 44
SPONTANEOUS TRANSFORMATION AND IMMORTALIZATION OF PERITONEAL- MACROPHAGES OF HUMAN-ORIGIN 42
Raman spectroscopy is able to discriminate between CD138-/CD138+ plasmacells of multiple myeloma patients 41
Flavonoid profile, antioxidant and cytotoxic activity of different extracts from Algerian Rhamnus alaternus L. bark 41
Characterization and functional analysis of the human microRNA 363 in glioblastoma transfected cell lines 41
Mature myeloid dendritic cell subsets have distinct roles for activation and viability of circulating human natural killer cells 40
Clinical drug response to thiopurines is associated with a lower interferon-γ production by IBD patient’s T lymphocytes 38
Dendritic cells generated either from CD34(+) progenitor cells or from monocytes differ in their ability to activate antigen-specific CD8(+) T cells 38
Human NK cells of mice with reconstituted human immune system components require pre-activation to acquire functional competence 38
Cross-dressing: an alternative mechanism for antigen presentation 38
Totale 10.946
Categoria #
all - tutte 44.372
article - articoli 41.782
book - libri 95
conference - conferenze 1.248
curatela - curatele 0
other - altro 0
patent - brevetti 202
selected - selezionate 0
volume - volumi 1.045
Totale 88.744


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021161 0 0 0 0 0 0 0 0 0 51 63 47
2021/2022830 30 74 59 81 35 49 54 206 48 67 34 93
2022/2023881 72 71 15 63 112 129 3 58 130 6 211 11
2023/2024915 19 64 38 164 96 227 19 31 37 38 73 109
2024/20252.149 35 215 118 103 306 233 218 285 40 112 192 292
2025/20263.550 444 105 323 353 444 363 658 195 326 339 0 0
Totale 12.545